Tectonic Therapeutic, Inc.
TECX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $293,603 | $371,172 | $303,862 | $682,975 |
| - Cash | $268,435 | $287,381 | $306,246 | $141,239 |
| + Debt | $1,238 | $1,943 | $2,632 | $3,303 |
| Enterprise Value | $26,406 | $85,734 | $248 | $545,039 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$19,021 | -$18,651 | -$15,526 | -$11,843 |
| % Margin | – | – | – | – |
| Net Income | -$19,035 | -$19,984 | -$15,906 | -$12,373 |
| % Margin | – | – | – | – |
| EPS Diluted | -1.02 | -1.07 | -0.93 | -0.84 |
| % Growth | 4.7% | -15.1% | -10.7% | – |
| Operating Cash Flow | -$17,815 | -$14,719 | -$13,083 | -$16,821 |
| Capital Expenditures | -$181 | -$27 | -$27 | -$3 |
| Free Cash Flow | -$17,996 | -$14,746 | -$13,110 | -$16,824 |